- ￥4848
- Merck
- 美国
- ABF13
- 2026年02月14日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 规格：
1件
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Tumor reactive monoclonal antibodies (mAb) have been developed and tested as anti-tumor therapy. Some mAb have shown efficacy and are now approved as clinical cancer therapy. The mechanism of action for the antitumor effect includes tumor
Antibodies for Inflammatory Disease: Cytokines
leukocytes and fibroblasts. Some cytokines are proinflammatory, such as interleukin-1 (IL-1) and tumor necrosis factor a (TNF-α); others, such as interleukin-10 (IL-10) and transforming growth factor β(TGF-β), exert predominantly anti-inflammatory effects
相关专题 &NBS p; Interleukin 10 Interleukin-10 (IL-10 or IL10), also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine. In humans IL-10 is encoded
技术资料暂无技术资料 索取技术资料
